Ground-breaking Research Gets to the Root of Permanent Hair Loss Amongst African Women
Professor Ncoza Dlova, the Dean of UKZN’s School of Clinical Medicine and internationally renowned Dermatologist, through her global collaborative work with a number of scientists; have identified a new gene that is a major cause of permanent hair loss amongst women of African descent. They discovered the root cause of Central Centrifugal Cicatricial Alopecia (CCCA), one of the most common causes of primary scarring alopecia amongst African women. This ground-breaking study, titled: Variant PAD13 in Central Centrifugal Cicatricial Alopecia, was published recently in the New England Journal of Medicine, one of the highest impact journals in medical science.
A team of investigators from the Department of Human Molecular Genetics and Dermatology from Israel’s Tel-Aviv University consisting of Professor Eli Sprecher, Dr Liron Malki, Dr Ofer Sarig; Professor Amy McMichael from the Department of Dermatology, Wake Forest Baptist Medical Center, USA; as well as other colleagues from the Institute of Human Genetics, University of Bonn in Germany; UDEAR; and Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier in France performed the genetic sequencing and coding as well clinical aspects of the research.
CCCA was first described in 1968 as “hot comb alopecia” in a series of African American women who straightened their hair with a hot comb. It is defined as hair loss or spot balding that starts from the central (crown) part of the scalp and radiates outward in a circular pattern. CCCA causes destruction of the hair follicles leading to scarring or permanent hair loss. It is very common amongst women of African descent between the ages of 30 and 60 years, and has a prevalence of 2, 7% - 5, 6%. The root cause of this condition has always been elusive and was attributed to the use of damaging chemical products on the hair, as well as the application of heat brushes, hot combs or straighteners. It has also often been confused with female pattern hair loss or common baldness - a completely different entity. The condition predominantly has no symptoms and maybe picked up co-incidentally by hairstylists, with very few individuals presenting with painful pimple like lesions on the scalp. It occurs rarely in African men, probably due to less hair manipulation.
Patients with CCCA were recruited from Durban, South Africa, from 2013 through to 2016 and in Winston-Salem, North Carolina, from 2014 through 2017.
This study found that the peptidylarginine deiminase 3 (PAD13) gene - which mediates posttranslational modification of proteins essential for proper hair shaft formation - was mutated in the majority of affected patients, suggesting that the disease is genetically heterogeneous.
The scientists also found that the distinct variants in PADI3 in each of the disorders may account for the difference in clinical outcomes.
These research findings suggest that PADI3 mutations predispose individuals to CCCA and clinical presentation or worsening of CCCA may be triggered by environmental factors such as damaging hair grooming practices including the use of hair chemicals, traction, heat, braids and weaves. This implies that in affected families, hair grooming practices as above, must be totally discouraged. Larger studies are still needed in order to justify genotyping of asymptomatic women.
‘Congratulations to Ncoza C Dlova whose very exciting work with her associates was published yesterday in the New England Journal of Medicine, titled: Variant PAD13 in Central Centrifugal Cicatricial Alopecia. CCCA is the most common cause of Cicatricial alopecia in people of African descent. This ground breaking work is the first to establish a genetic basis for this vexing cause of alopecia. Kudos Prof!’ said Dr Umar Sumer, the Los Angeles Hair Transplant Group Leader.
Dr Sarina Drusinsky, Dermatology Society of South Africa Secretary, said: ‘Congratulations from myself and the DSSA on your wonderful achievement and the publication in the New England Journal of Medicine. I personally am in awe of how you manage to do everything that you do and always do it so outstandingly. As my children say, “you rock”. Once again a heartfelt congratulations to you Ncoza’.
African Women’s Dermatology Society (AWDS) executive members Dr Dagmar Whitaker, Professor Anisa Mosam and Secretary, Dr Nokubonga Khoza, also sent through congratulatory remarks; ‘We are bursting with pride for Prof Dlova and her associate’s ground-breaking work. You can consider yourself amongst the best in the field to have made such a finding which is going to change how we manage this challenging condition. What a time to be alive.’
Commenting on this exciting finding, Dlova said, ‘This is probably the biggest breakthrough in South African dermatology. This discovery is a first in the world, and it followed links to an earlier publication of 2013 in which we reported for the first time a familial association in a cluster of Black South African families with CCCA. We have been following the 15 families for five years and seven years later, a gene has been identified. This has huge implications on early diagnosis, prevention and possible future targeted therapy of CCCA. None of this would have been possible without the families and our patients who showed the will to participate in our research endeavours. We are indeed grateful to them. I am also grateful to my local and international colleagues for working with me. This is indeed testimony to the power of diversity and working together in research,’ said Dlova, adding: ‘Thanks also to my supportive family in the Department of Dermatology fondly known as “DOD”, UKZN, as well as my heroes, my husband Dr Themba Mabaso, son Wakithi Mabaso and my family.’ I also thank Prof Dedee Murrell from Australia, for introducing me to Prof Eli Sprecher, a real geneticist genius indeed.
‘We are also eternally grateful to all our sponsors. The Ram Family Foundation, the German–Israeli Foundation, L’Oreal African Hair and Skin Research grant, the Skin of Color Society, and the Deutsche Forschungsgemeinschaft–funded Cluster of Excellence ImmunoSensation as well as Dr Nokubonga Khoza for assisting with patient recruitment.’
Words: MaryAnn Francis